View Email as a Web Page
Remdesivir for the treatment of COVID-19
In this recently published Cochrane review, authors explored the effects of treating COVID-19 with remdesivir, an antiviral medication.
Interview: Cochrane and NICE collaborate to improve health guidelines
Cochrane are siging a collaboration licence agreement with NICE, the National Institute for Health and Care Excellence, the UK government’s guideline organization.
Apply now: the 2021 Cochrane-REWARD prize for reducing waste in research
Nominations are open for the 2021 Cochrane-REWARD prize, which recognizes initiatives that have potential to reduce research waste.
Deadline for submissions: 24 September
Featured Reviews:
Podcasts
Download the free Cochrane Library App on your
iPhone, iPad, or Android
Copyright © 2021 Cochrane, All rights reserved.Registered in England as a company limited by guarantee No. 03044323 Charity Number 1045921. Registered office: St Albans House 57-59 Haymarket London, SW1Y 4QX United Kingdom
To update your communication preferences please visit your Cochrane Account. Or to unsubscribe from all updates and newsletters you can unsubscribe here. If you have any questions please email support@cochrane.org